Benzinga

APRIL 27, 2022

Pfizer Inc (NYSE: PFE ) and BioNTech SE (NASDAQ: BNTX ) have submitted an FDA Emergency Use Authorization (EUA) application for a 10-µg booster dose of COVID-19 Vaccine for children 5 through 11 years of age. Click here to access Benzinga's FDA Calendar. The FDA has granted. Stocks In Focus.

Finance 97

Finance 97

Benzinga

APRIL 13, 2022

Click here to access Benzinga's FDA Calendar. Sierra's momelotinib complements GSK's Blenrep, building on GSK's commercial and medical expertise in hematology. SRRA shares are gaining 37.8% during the premarket trading. ProQR Discontinues Working On Inherited Retinal Disease Programs. ProQR Therapeutics N.V.

Equity 98

Equity Technology 98

Benzinga

JANUARY 31, 2024

In exchange, Metalmark shall receive a royalty of 5% of the net revenue of Octomera's cell processing services, for the three calendar years 2025-2027, along with a portion of the proceeds attributable to Octomera's cell processing services should there be a change of control in the next 10 years.

Marketability 40

Marketability 40

ThomsonReuters

MARCH 24, 2022

For example, if your plan operates on a calendar year, and a recommendation is adopted on July 1, 2022, your plan would be required to cover those services beginning January 1, 2024.

Compliance 52

Compliance 52

Benzinga

OCTOBER 26, 2022

MYFEMBREE was approved by the FDA in August 2022 for the management of moderate to severe pain associated with endometriosis, establishing it as the first and only once-daily oral gonadotropin-releasing hormone (GnRH) antagonist treatment approved for both uterine fibroids and endometriosis. Food and Drug Administration (FDA).

Start-ups 40

Start-ups Marketability Technology 40

ThomsonReuters

JANUARY 13, 2022

Since then, the FDA has authorized additional COVID-19 diagnostic tests, including OTC tests that can be self-administered and self-read at home without the involvement of a health care provider. Fraud and Abuse.

98

98